Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1

Acute myeloid leukemia (AML) with BCR-ABL1 is rare and has a poor prognosis with conventional chemotherapy or ABL tyrosine kinase inhibitors (TKIs) alone. We reported a case of AML with BCR-ABL1 patient who was successfully treated with dasatinib alone; additionally, we previously reported another c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Leuk Res Rep
Hlavní autoři: Takeuchi, Asako, Kondo, Toshinori, Tasaka, Taizo, Yamada, Seiko, Hirose, Tadashi, Fukuda, Hirofumi, Shimizu, Risa, Matsuhashi, Yoshiko, Kondo, Eisei, Wada, Hideho
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7758353/
https://ncbi.nlm.nih.gov/pubmed/33376671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2020.100233
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky